A Cure in Sight is joined by fellow OM patient, Clay Butler, diagnosed with a choroidal ocular melanoma on New Year’s Eve, 2021. He opted for enucleation on 2/22/22.

In this episode, Clay shares his story, including the discovery and diagnosis of his eye tumor, the treatment options he weighed and why, his enucleation journey thus far, and what is his focus presently.

He shares empowering mindsets that help in navigating many phases of this diagnosis; one such thought being the question: What am I missing out on, vs what I can DO about this?

His episode is jam packed with insights and ideas.

You can get to know Clay a little more through some of his work in the links below, and connect with him on Facebook, or Instagram (@twilight.ninja).


ANNOUNCEMENTS:

Save the date for our Eye Believe Survivorship Seminar in Nashville!!

October 13-15! Virtual is only 14-15. REGISTER HERE!

*********
Be sure to follow us on Facebook, Twitter, or  Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!
*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more! Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure. LINKS TO PAYPAL OR VENMO 
The Eye Believe Podcast is brought to you by Castle Biosciences. Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors. 
This podcast was hosted by Danet Peterson and produced by Agora Media.